BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 14751139)

  • 21. A modified shortened administration schedule for neoadjuvant chemotherapy with irinotecan and cisplatin in locally advanced cervical cancer.
    Ren Y; Li Y; Liu J
    Int J Gynecol Cancer; 2011 May; 21(4):685-9. PubMed ID: 21543932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
    Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I study with weekly cisplatin-paclitaxel and concurrent radiotherapy in patients with carcinoma of the cervix uteri.
    Pignata S; Frezza P; Tramontana S; Perrone F; Tambaro R; Casella G; Ferrari E; Iodice F; De Vivo R; Ricchi P; Tramontana F; Silvestro G
    Ann Oncol; 2000 Apr; 11(4):455-9. PubMed ID: 10847466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Weekly topotecan and cisplatin (TOPOCIS) as neo-adjuvant chemotherapy for locally-advanced squamous cervical carcinoma: Results of a phase II multicentric study.
    Zanaboni F; Grijuela B; Giudici S; Cormio G; Babilonti L; Ghezzi F; Giorda G; Scambia G; Franchi M; Lorusso M; Ditto A; Lorusso D; Raspagliesi F
    Eur J Cancer; 2013 Mar; 49(5):1065-72. PubMed ID: 23151423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II trial on cisplatin-adriamycin-paclitaxel combination as neoadjuvant chemotherapy for locally advanced cervical adenocarcinoma.
    Lorusso D; Ramondino S; Mancini M; Zanaboni F; Ditto A; Raspagliesi F
    Int J Gynecol Cancer; 2014 May; 24(4):729-34. PubMed ID: 24662130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Rose PG; Blessing JA; Gershenson DM; McGehee R
    J Clin Oncol; 1999 Sep; 17(9):2676-80. PubMed ID: 10561341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neoadjuvant chemotherapy with cisplatin and CPT-11 for advanced cervical cancer].
    Nishio S; Kumagai S; Hirai N; Tomioka Y; Oota S; Fujiyoshi K; Hasuo Y; Sugiyama T; Nishida T; Kamura T
    Gan To Kagaku Ryoho; 2000 Mar; 27(3):429-35. PubMed ID: 10740637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
    Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response to neoadjuvant chemotherapy with paclitaxel and cisplatin in locally advanced cervical cancer.
    Mousavia AS; Vahidi S; Karimi-Zarchi M; Modarress-Gilania M; Ghaemmaghamia F
    Eur J Gynaecol Oncol; 2013; 34(6):527-31. PubMed ID: 24601044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neoadjuvant chemotherapy with cisplatin, ifosfamide and paclitaxel for locally advanced squamous-cell cervical cancer.
    Zanetta G; Lissoni A; Pellegrino A; Sessa C; Colombo N; Gueli-Alletti D; Mangioni C
    Ann Oncol; 1998 Sep; 9(9):977-80. PubMed ID: 9818071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase II trial with cisplatin-paclitaxel cytotoxic treatment and concurrent external and endocavitary radiation therapy in locally advanced or recurrent cervical cancer.
    Miglietta L; Franzone P; Centurioni MG; Boni L; Tacchini L; Cosso M; Boccardo F; Ferrarini M; Bruzzone M
    Oncology; 2006; 70(1):19-24. PubMed ID: 16439862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of ifosfamide, paclitaxel, and cisplatin for the treatment of metastatic and recurrent carcinoma of the uterine cervix: a phase II study of the Hellenic Cooperative Oncology Group.
    Dimopoulos MA; Papadimitriou CA; Sarris K; Aravantinos G; Kalofonos C; Gika D; Gourgoulis GM; Efstathiou E; Skarlos D; Bafaloukos D
    Gynecol Oncol; 2002 Jun; 85(3):476-82. PubMed ID: 12051877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
    Ilson DH; Ajani J; Bhalla K; Forastiere A; Huang Y; Patel P; Martin L; Donegan J; Pazdur R; Reed C; Kelsen DP
    J Clin Oncol; 1998 May; 16(5):1826-34. PubMed ID: 9586897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neoadjuvant gemcitabine and cisplatin followed by radical surgery in (bulky) squamous cell carcinoma of cervix stage IB2.
    Termrungruanglert W; Tresukosol D; Vasuratna A; Sittisomwong T; Lertkhachonsuk R; Sirisabya N
    Gynecol Oncol; 2005 May; 97(2):576-81. PubMed ID: 15863162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concurrent chemoradiotherapy with paclitaxel and nedaplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: preliminary results of a phase II study.
    Zhang MQ; Liu SP; Wang XE
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):821-7. PubMed ID: 20207507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neoadjuvant chemotherapy and conservative surgery for stage IB1 cervical cancer.
    Maneo A; Chiari S; Bonazzi C; Mangioni C
    Gynecol Oncol; 2008 Dec; 111(3):438-43. PubMed ID: 18835493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical effects of combination chemotherapy with irinotecan hydrochloride and cisplatin on cervical cancer: study of 46 patients].
    Wang CY; Ma D; Zhu T; Chen SY; Zhang QH; Song XJ; Chen TH; Gu MJ
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2104-8. PubMed ID: 16313818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical cancer.
    Adachi S; Ogasawara T; Tsubamoto H; Oku H; Hori Y; Tsuji Y; Takemura T; Koyama K
    Int J Clin Pharmacol Res; 2001; 21(3-4):105-10. PubMed ID: 12067139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neoadjuvant treatment of locally advanced carcinoma of the uterine cervix with epirubicin, paclitaxel and cisplatin.
    D'Agostino G; Distefano M; Greggi S; Salerno M; Ferrandina G; Poerio A; Mancuso S; Scambia G
    Cancer Chemother Pharmacol; 2002 Mar; 49(3):256-60. PubMed ID: 11935219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study.
    Lissoni AA; Colombo N; Pellegrino A; Parma G; Zola P; Katsaros D; Chiari S; Buda A; Landoni F; Peiretti M; Dell'anna T; Fruscio R; Signorelli M; Grassi R; Floriani I; Fossati R; Torri V; Rulli E
    Ann Oncol; 2009 Apr; 20(4):660-5. PubMed ID: 19181826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.